Nutritional Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Muscle Atrophy

NCT01344135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2018-04-30

No results posted yet for this study

Summary

To study in clinically stable Chronic Obstructive Pulmonary Disease (COPD) patients with muscle atrophy:

1. The short-term effects of 4 months exercise training including nutritional supplementation versus exercise training alone on physical functioning (skeletal muscle strength and exercise capacity) and body composition.
2. The long-term effects of 4 months of exercise training and nutritional supplementation followed by 8 months of nutritional counseling (with supplementation on advice) and feedback on physical activity level versus 4 months of exercise training and 8 months with feedback on physical activity level alone on physical functioning, body composition and cardiometabolic risk profile;
3. The cost-effectiveness of exercise rehabilitation and nutritional intervention versus exercise rehabilitation alone.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Muscular Atrophy

Interventions

DIETARY_SUPPLEMENT

Dietary supplementation

Phase A, Rehabilitation (4 months): 3 nutritional supplements daily Phase B, Maintenance (8 months): nutritional supplementation on advice (1 supplement daily) Phase C, Follow-up (3 months): no supplementation

DIETARY_SUPPLEMENT

Placebo supplement

Phase A, Rehabilitation (4 months): 3 placebo nutritional supplements daily Phase B, Maintenance (8 months): No supplementation Phase C, Follow-up (3 months): No supplementation

BEHAVIORAL

Nutritional counselling

Phase A, Rehabilitation (4 months): No counselling Phase B, Maintenance (8 months): Nutritional counselling (4x) Phase C, Follow-up (3 months): No counselling Aim: 1. Optimising dietary intake to physical activity pattern and energy expenditure. 2. Minimize deterioration of dietary intake during acute exacerbations. 3. Optimize dietary lipid profile with respect to total fat intake; trans fatty acids and proportion of poly-unsaturated fatty acids to modulate cardiovascular risk and muscle fatty acid metabolism. 4. Increasing adherence/compliance by addressing issues like taste fatigue, gastro-intestinal symptoms, individual preferences and lifestyle.

BEHAVIORAL

Feedback on physical activity level

Phase A, Rehabilitation (4 months): No exercise counselling Phase B, Maintenance (8 months): Exercise counselling (2x) Phase C, Follow-up (3 months): No exercise counselling Aim: 1. Integration of exercise behaviour into daily routine 2. Improvement of self-regulation skills (e.g. self-monitoring, goal setting, action planning) 3. Increasing adherence/compliance by addressing issues like coping with difficult situation, individual preferences and lifestyle

Sponsors & Collaborators

  • The Netherlands Asthma Foundation

    collaborator OTHER
  • Danone Global Research & Innovation Center

    collaborator INDUSTRY
  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Annemie Schols, Prof. · Maastricht UMC+ / NUTRIM, Respiratory Medicine

  • Maureen Rutten, Dr. · Erasmus Medical Centre, Institute for Medical Technology Assessment

  • Emiel FM Wouters, Prof. · Maastricht UMC+ and CIRO, Respiratory Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344135 on ClinicalTrials.gov